Recent studies have revealed that the ?epitranscriptome,? i.e., the pattern and distribution of RNA modifications in mRNA, is dynamically regulated and has functional roles in the brain. Our laboratory had a founding role in the emergence of this field with our initial transcriptome-wide map of N6-methyladenosine (m6A), which revealed that m6A is present in over 8,000 different transcripts, and is predominantly located near stop codons and in the 5'UTR of mRNAs. Although m6A has been studied in standard tissue culture cell lines, the effects of m6A on mRNA in neurons remain unclear. Our data suggests that m6A may function as a cis-acting element that targets diverse mRNAs to dendrites. We also find that FMRP, a major RNA-binding protein linked to cognitive function, may bind a subset of m6A residues, i.e., the ones in the coding regions of mRNAs. These m6A sites show high overlap with known FMRP-binding sites in the transcriptome and depleting m6A from mRNAs markedly impairs the ability of FMRP to associate with translating ribosomes, which is believed to be essential for its translation-inhibitory effect. In order to significantly advance our understanding of these novel roles of m6A in neuronal function, the specific aims of this proposal are: (1) To image m6A mRNAs: Technologies for imaging m6A-mRNA trafficking in living cells and selective detection of m6A-mRNA in fixed cells. In this aim, we will develop two methods for imaging m6A-RNAs, one for live cells and one for fixed tissue. For live cell imaging, we will use a highly optimized MS2 system to image reporter RNAs that have been engineered to be resistant or susceptible to endogenous methylation. For fixed cell imaging, we have devised FISH-FRET, a fundamentally new approach for transcript- and m6A site-specific imaging of mRNA in virtually any cell or tissue. (2) To determine the role of m6A in mRNA trafficking and local translation. In this aim, we will test the role of m6A in mediating mRNA trafficking to axons and dendrites and how m6A influences local translation at these sites. (3) To determine if FMRP controls the function of mRNAs containing m6A in the coding sequence. In this aim, we will establish if FMRP's transcriptome-wide binding properties, granule formation and mobility in neurons are affected by m6A. We will also probe how FMRP controls translation and if its translation-inhibitory effect is directed towards mRNAs that contain m6A in their coding sequence. Although m6A is a highly abundant modification in neuronal mRNA, its functions remain unclear. Our studies point to key roles of m6A in directing mRNAs to dendrites and in mediating the assembly of FMRP onto stalled ribosomes and potentially FMRP granules. Our proposed studies have the potential to fundamentally alter our understanding of local translation, mRNA trafficking, FMRP function, and RNA regulatory mechanisms in the brain.

Public Health Relevance

Recent studies have shown that mRNA can be dynamically regulated by methylation of specific adenosine residues to form N6-methyladenosine (m6A), an ?epitranscriptomic? mark that occurs on a subset of mRNAs. m6A appears to be particularly important in brain and our early studies suggest that m6A could have important roles in various aspects of neuronal function and neuronal protein expression. This proposal will develop technologies to directly image m6A-containing mRNA in neurons and to determine functional role for m6A in mediating mRNA trafficking and mRNA regulation by the fragile X mental retardation protein (FMRP).

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS056306-11
Application #
9473457
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Mamounas, Laura
Project Start
2007-06-01
Project End
2022-07-31
Budget Start
2017-09-30
Budget End
2018-07-31
Support Year
11
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Kim, Ju Youn; Jaffrey, Samie R (2016) Separating neuronal compartments gives clues as to local effect of ubiquitin conjugates in synaptogenesis. J Cell Biol 212:751-3
Deglincerti, Alessia; Liu, Yaobin; Colak, Dilek et al. (2015) Coupled local translation and degradation regulate growth cone collapse. Nat Commun 6:6888
Harkcom, William T; Ghosh, Ananda K; Sung, Matthew S et al. (2014) NAD+ and SIRT3 control microtubule dynamics and reduce susceptibility to antimicrotubule agents. Proc Natl Acad Sci U S A 111:E2443-52
Lundquist, Mark R; Storaska, Andrew J; Liu, Ting-Chun et al. (2014) Redox modification of nuclear actin by MICAL-2 regulates SRF signaling. Cell 156:563-76
Colak, Dilek; Zaninovic, Nikica; Cohen, Michael S et al. (2014) Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome. Science 343:1002-5
Brown, Kevin D; Maqsood, Sadia; Huang, Jing-Yi et al. (2014) Activation of SIRT3 by the NAD? precursor nicotinamide riboside protects from noise-induced hearing loss. Cell Metab 20:1059-68
Ji, Sheng-Jian; Jaffrey, Samie R (2014) Axonal transcription factors: novel regulators of growth cone-to-nucleus signaling. Dev Neurobiol 74:245-58
Hess, Martin E; Hess, Simon; Meyer, Kate D et al. (2013) The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry. Nat Neurosci 16:1042-8
Colak, Dilek; Ji, Sheng-Jian; Porse, Bo T et al. (2013) Regulation of axon guidance by compartmentalized nonsense-mediated mRNA decay. Cell 153:1252-65
Curanovic, Dusica; Cohen, Michael; Singh, Irtisha et al. (2013) Global profiling of stimulus-induced polyadenylation in cells using a poly(A) trap. Nat Chem Biol 9:671-3

Showing the most recent 10 out of 17 publications